Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/elyvCfbwocfDdoaxPVKX

February 28, 2013
What are the 5 keys to success for small biotech companies entering China? Find out on BIOtechNOW.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at bio@smartbrief.com.

  Today's Top Story 
 
  • Biosimilar drugs' cost-savings still out of reach
    The prospect of reducing health care costs through use of biosimilar drugs has has hit roadblocks in the form of setbacks for development programs and regulatory hurdles. The FDA is still crafting a pathway for approval. "There has been a little bit of volatility" in the push for biosimilars, said Merck vice president Richard Murray as the company formed a new partnership with Samsung. The Wall Street Journal (2/26) LinkedInFacebookTwitterEmail this Story
7 keys: Put real-world evidence into action
Life sciences organizations need to know how their therapies work in the real world once clinical trials end. And these seven key components to standardizing real-world data and analytics platforms are how they get started. Read the paper, Institutionalizing Real World Evidence.
ADVERTISEMENT
  Health Care & Policy 
  • Kan. bill would establish adult stem cell facility moves forward
    The Kansas Senate Public Health and Welfare Committee on Tuesday approved legislation that would establish the Midwest Stem Cell Therapy Center at the University of Kansas Medical Center. The facility, intended to become a regional hub for adult stem cell research and treatment, will focus on producing clinical-grade stem cells from adult tissues, cord blood and other such materials. Embryonic stem cells would not be allowed at the facility. The Topeka Capital-Journal (Kan.) (2/26) LinkedInFacebookTwitterEmail this Story
  • Ore. team grows liver stem cells in culture
    Scientists at Oregon Health and Science University have developed a method of cultivating liver stem cells in culture. The cells thrived following transplantation in a mouse model, according to a report in the journal Nature. "This study raises the hope that the human equivalent of these mouse liver stem cells can be grown in a similar way and efficiently converted into functional liver cells," Dr. Markus Grompe said. Yahoo/Asian News International (2/26) LinkedInFacebookTwitterEmail this Story
  Company & Financial News 
  • Wis. biotech Invenra raises $3M
    Biotech startup Invenra said in a regulatory filing that it secured $3 million in financing. The Madison, Wis.-based firm has a novel drug discovery platform for biologics that it says can "screen billions of novel peptides and proteins for intracellular biological activity in less than a week." MedCityNews.com (2/27) LinkedInFacebookTwitterEmail this Story
  Industry Deals 
  Food & Agriculture 
  • More Canadian farmers growing biotech crops
    Canada's total planted area of biotech crops reached almost 29 million acres last year, making it the world's fourth biggest grower of biotech seeds, up from fifth in 2011, a report showed. "Farmers continue to embrace these types of crops because of the benefits they see in terms of improved yields and quality," said Stephen Yarrow of CropLife Canada. The London Free Press (Ontario) (2/27) LinkedInFacebookTwitterEmail this Story
  Industrial & Environmental 
  • Exec: DuPont has an edge in cellulosic ethanol development
    DuPont has a better shot at bringing cellulosic ethanol to the market than other companies because it has been working on the technology for 10 years now, CEO Ellen Kullman said. Aside from its wealth of experience, DuPont has a feedstock supply chain in place that could serve the plant it is building in Iowa, Kullman said. "We keep building on our learnings from previous projects and it's helping us do it faster and understand what we need from others and I think it's going to create a huge potential for success," Kullman said. GigaOm (2/27) LinkedInFacebookTwitterEmail this Story
 
The Buzz(CORPORATE ANNOUNCEMENTS)

Interested in learning more about advertising in BIO SmartBrief? Contact Meryl Harold at (202) 407-7828 or mharold@smartbrief.com. 

  News from BIO 
  • Ship with FedEx
    FedEx is now offering member companies discounts of up to 35% off select FedEx services, both U.S. and international services. The BIO program with FedEx is one of the many cost-savings programs offered by BIO through its Business Solutions program. There is no charge for BIO member companies to participate in any of the BIO Business Solutions programs -- it is a benefit of membership. Learn more about the BIO and FedEx program. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

  SmartQuote 
He that will not apply new remedies must expect new evils; for time is the greatest innovator."
--Francis Bacon,
British author and statesman


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information